Home/Pipeline/Generic Portfolio Development

Generic Portfolio Development

Various (including rare diseases)

ANDA Filed/DevelopmentActive

Key Facts

Indication
Various (including rare diseases)
Phase
ANDA Filed/Development
Status
Active
Company

About Analog Pharma

Analog Pharma, founded in 2016 and headquartered in Boston, is a private generic drug manufacturer focused on quality and access, particularly for orphan and rare disease medications. The company emphasizes a supply chain strategy of reshoring and nearshoring to guarantee product continuity. As part of the Duchesnay Pharmaceutical Group, it operates commercially in the US market with a portfolio that includes products like nitisinone and doxylamine succinate/pyridoxine hydrochloride.

View full company profile